[1]. Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072. [2]. Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551-4556. [3]. Horwath MC, et al. Antifungal Activity of the Lipophilic Antioxidant Ferrostatin-1. Chembiochem. 2017;18(20):2069-2078. [4]. Liu P, Feng Y, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett. 2020;25:10. [5]. Guerrero Hue M, et al. FP282 Ferroptosis-mediated cell death is decreased by curcumin in renal damage associated to rhabdomyolysis. Nephrology Dialysis Transplantation. 2019;34(Suppl 1):gfz106.FP282. [6]. Zhang M, et al. Ferrostatin-1 attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis. Transl Pediatr. 2023 Nov 28;12(11):1944-1970. [7]. Cheon YI, et al. Effect of deferoxamine and ferrostatin-1 on salivary gland dysfunction in ovariectomized rats. Aging (Albany NY). 2023 Apr 6;15(7):2418-2432. [8]. Morrow JP, et al. Poly(2-oxazoline)-Ferrostatin-1 drug conjugates inhibit ferroptotic cell death. J Control Release. 2022;350:193-203. [9]. Xie Q, et al. Ferrostatin-1 improves BMSC survival by inhibiting ferroptosis. Arch Biochem Biophys. 2023 Mar 1;736:109535. [10]. Chu J, et al. Ferrostatin-1 protects HT-22 cells from oxidative toxicity. Neural Regen Res. 2020;15(3):528-536. [11]. Xie J, et al. Ferrostatin-1 alleviates oxalate-induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis. Mol Med Rep. 2022 Aug;26(2):256. [12]. Ling M, et al. Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis. Int Immunopharmacol. 2023;120:110356. [13]. Teng Y, et al. Ferrostatin-1 ameliorates UVB-induced damage of HaCaT cells by regulating ferroptosis. Exp Dermatol. 2024;33(2):e15018. [14]. Li S, et al. Ferrostatin-1 alleviates angiotensin II (Ang II)-induced inflammation and ferroptosis in astrocytes. Int Immunopharmacol. 2021;90:107179. [15]. Liu N, et al. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance. Br J Cancer. 2020;122(2):279-292. [16]. Zhang Z, et al. CGI1746 targets σ1R to modulate ferroptosis through mitochondria-associated membranes. Nat Chem Biol. 2024;20(6):699-709. [17]. Hanke N, et al. Inhibition of autophagy rescues HT22 hippocampal neurons from erastin-induced ferroptosis. Neural Regen Res. 2023;18(7):1548-1552. [18]. Wang X, et al. Melatonin alleviates acute sleep deprivation-induced memory loss in mice by suppressing hippocampal ferroptosis. Front Pharmacol. 2021;12:708645. [19]. Du J, et al. Identification of Frataxin as a regulator of ferroptosis. Redox Biol. 2020;32:101483. [20]. Cheff DM, et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 2023;62:102703.
此外,MCE 顾客使用本产品已发表 1,709 篇科研文献。
五、品牌实力与产品保障体系
Fer-1 所属品牌 MedChemExpress(MCE)提供抑制剂、激动剂、拮抗剂、激活剂、调节剂、降解剂、配体和底物等多种生物活性化合物,可用于靶点功能验证、信号转导机制研究、细胞表型分析、疾病机制研究、药效评价及活性化合物筛选。MCE 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶 / 受体酪氨酸激酶、干细胞 / Wnt、TGF-β/Smad 及维生素 D / 核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,已助力客户发表文献超 80,000 篇。